BG107530A - Нови съединения и тяхното използване като инхибитори на глициновия транспортер - Google Patents

Нови съединения и тяхното използване като инхибитори на глициновия транспортер Download PDF

Info

Publication number
BG107530A
BG107530A BG107530A BG10753003A BG107530A BG 107530 A BG107530 A BG 107530A BG 107530 A BG107530 A BG 107530A BG 10753003 A BG10753003 A BG 10753003A BG 107530 A BG107530 A BG 107530A
Authority
BG
Bulgaria
Prior art keywords
alkyl
phenyl
dihydroisobenzofuran
chloro
halogen
Prior art date
Application number
BG107530A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ejner Moltzen
Paul Smith
Christian Krog-Jensen
Klaus Bogeso
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG107530A publication Critical patent/BG107530A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107530A 2000-07-21 2003-02-05 Нови съединения и тяхното използване като инхибитори на глициновия транспортер BG107530A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001124 2000-07-21
PCT/DK2001/000510 WO2002008216A1 (en) 2000-07-21 2001-07-19 Novel compounds and their use as glycine transport inhibitors

Publications (1)

Publication Number Publication Date
BG107530A true BG107530A (bg) 2003-09-30

Family

ID=8159626

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107530A BG107530A (bg) 2000-07-21 2003-02-05 Нови съединения и тяхното използване като инхибитори на глициновия транспортер

Country Status (28)

Country Link
US (1) US6921774B2 (de)
EP (1) EP1301502B1 (de)
JP (1) JP2004504393A (de)
KR (1) KR20030015889A (de)
CN (1) CN100509791C (de)
AR (1) AR032358A1 (de)
AT (1) ATE295844T1 (de)
AU (2) AU8174001A (de)
BG (1) BG107530A (de)
BR (1) BR0113011A (de)
CA (1) CA2416447A1 (de)
CZ (1) CZ2003396A3 (de)
DE (1) DE60110914T2 (de)
EA (1) EA005621B1 (de)
ES (1) ES2238466T3 (de)
HR (1) HRP20030053A2 (de)
HU (1) HUP0302778A3 (de)
IL (2) IL153988A0 (de)
IS (1) IS6693A (de)
MX (1) MXPA03000642A (de)
NO (1) NO20030243L (de)
NZ (1) NZ523720A (de)
PL (1) PL364439A1 (de)
PT (1) PT1301502E (de)
SK (1) SK2022003A3 (de)
UA (1) UA75081C2 (de)
WO (1) WO2002008216A1 (de)
ZA (1) ZA200300514B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060004967A (ko) * 2003-04-30 2006-01-16 하. 룬트벡 아크티에 셀스카브 방향족 옥시페닐 및 방향족 설파닐페닐 유도체
CN1867358A (zh) * 2003-08-21 2006-11-22 H.隆德贝克有限公司 用于治疗抑郁症的5－羟色胺再摄取抑制剂和1型甘氨酸转运蛋白抑制剂的联合药物
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
JP2007528879A (ja) * 2004-03-12 2007-10-18 ハー・ルンドベック・アクチエゼルスカベット フェニルインダン誘導体
WO2005100301A1 (en) * 2004-03-31 2005-10-27 Eli Lilly And Company 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
WO2006000222A2 (en) * 2004-06-24 2006-01-05 H. Lundbeck A/S The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia
JP5109974B2 (ja) * 2006-07-18 2012-12-26 アステラス製薬株式会社 アミノインダン誘導体又はその塩
ES2392105T3 (es) * 2006-08-30 2012-12-04 F. Hoffmann-La Roche Ag Inhibidores de GlyT-1
US20100083581A1 (en) * 2007-06-18 2010-04-08 Mattice Douglas A Environmental brush seal
EP2389187B1 (de) 2009-01-20 2016-11-16 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Sorbin- und benzoesäure und derivate daraus zur verstärkung der wirkung eines neuropharmakons
EP2380595A1 (de) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Zusammensetzungen und Verfahren zur selektiven Abgabe von Oligonukleotidmolekülen an spezifische Neuronentypen
US9700563B2 (en) * 2012-09-06 2017-07-11 MediSynergies, LLC Kappa opioid receptor compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166711A (en) * 1966-03-28 1969-10-08 Kefalas As Process for the Preparation of Phenyl-Indane and -Tetralin Derivatives
US3549656A (en) * 1967-12-28 1970-12-22 Kefalas As Antidepressant 1 - aminoalkyl - thiophthalanes and acid addition salts thereof
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US5225323A (en) 1988-11-21 1993-07-06 Baylor College Of Medicine Human high-affinity neurotransmitter uptake system
CA2123323A1 (en) 1991-11-12 1993-05-27 Neurogenetic Corporation Dna encoding a glycine transporter and uses thereof
US5824486A (en) 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
US6008015A (en) 1997-04-11 1999-12-28 Allelix Neuroscience Inc. Glycine transporter
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6566550B2 (en) * 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport

Also Published As

Publication number Publication date
EA005621B1 (ru) 2005-04-28
KR20030015889A (ko) 2003-02-25
BR0113011A (pt) 2003-07-01
NO20030243L (no) 2003-03-06
DE60110914T2 (de) 2005-10-27
IL153988A0 (en) 2003-07-31
IS6693A (is) 2003-01-20
EP1301502B1 (de) 2005-05-18
CA2416447A1 (en) 2002-01-31
US20030181445A1 (en) 2003-09-25
AR032358A1 (es) 2003-11-05
US6921774B2 (en) 2005-07-26
MXPA03000642A (es) 2003-06-06
CZ2003396A3 (cs) 2003-05-14
UA75081C2 (en) 2006-03-15
HUP0302778A2 (hu) 2003-12-29
PL364439A1 (en) 2004-12-13
HRP20030053A2 (en) 2005-02-28
JP2004504393A (ja) 2004-02-12
NZ523720A (en) 2004-07-30
IL153988A (en) 2006-10-05
EA200300180A1 (ru) 2003-06-26
EP1301502A1 (de) 2003-04-16
ZA200300514B (en) 2004-08-20
NO20030243D0 (no) 2003-01-17
AU8174001A (en) 2002-02-05
AU2001281740B2 (en) 2006-02-16
ES2238466T3 (es) 2005-09-01
WO2002008216A1 (en) 2002-01-31
DE60110914D1 (de) 2005-06-23
SK2022003A3 (en) 2003-06-03
PT1301502E (pt) 2005-09-30
CN1662519A (zh) 2005-08-31
ATE295844T1 (de) 2005-06-15
CN100509791C (zh) 2009-07-08
HUP0302778A3 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
TWI543974B (zh) 苯基－３－氮雜－雙環［３．１．０］己－３－基－甲酮及其作為藥物之用途
US11111210B2 (en) Phenyl cyclohexanone derivatives and methods of making and using them
TW201902893A (zh) 細胞凋亡誘導劑
BG107530A (bg) Нови съединения и тяхното използване като инхибитори на глициновия транспортер
US10106523B2 (en) Amide compound
DE19952147A1 (de) Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JP2023501620A (ja) 複素環式ｔｒｐｍｌ１アゴニスト
KR20120084771A (ko) 브래디키닌 수용체 길항제로서 유용한 2-아릴-프로피온아미드 유도체 및 이를 함유하는 약학적 조성물
JP2008509962A (ja) ５−ｈｔ７受容体アンタゴニスト
AU2001281740A1 (en) Novel compounds and their use as glycine transport inhibitors
JP2003513970A (ja) 中枢神経系障害の治療のための［（インドール−３−イル）−シクロアルキル］−３−置換アゼチジン
JP2019516736A (ja) 疼痛に対する多様な活性を有するテトラヒドロピラン誘導体およびチオピラン誘導体
AU3964393A (en) Novel amidoalkyl- and imidoalkyl-piperazines
JP4937347B2 (ja) 置換フェニルメタノン誘導体
JP6401156B2 (ja) イミダゾ［２，１−ｂ］チアゾール誘導体、その製造方法、および医薬品としての使用
JP6844822B2 (ja) 疼痛に対して活性を有する置換モルホリン誘導体
KR20020084091A (ko) 신규 이미다졸 유도체
JP2018531263A6 (ja) 疼痛に対して活性を有するオキサジアザスピロ化合物
JP2018531263A (ja) 疼痛に対して活性を有するオキサジアザスピロ化合物
TWI454470B (zh) 硫苯並薁丙酸衍生物之製造法
JP3786983B2 (ja) ピロリジノン誘導体
WO2022111473A1 (en) Compounds as mrgprx2 antagonists
KR101837957B1 (ko) ｍＧｌｕＲ5 길항제로서의 활성을 가지는 티아졸-2-카르복사아마이드 유도체
KR20150090769A (ko) 아릴옥시 아제티딘 화합물, 및 이를 포함하는 약학 조성물
JP2003510309A (ja) 置換ベンゾイミダゾール誘導体、その製造方法及びその医薬組成物としての使用